» Articles » PMID: 31151712

Referral to Cardiology Following Postpartum Cardiovascular Risk Screening at the Maternal Health Clinic in Kingston, Ontario

Overview
Journal Can J Cardiol
Publisher Elsevier
Date 2019 Jun 2
PMID 31151712
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiovascular disease (CVD) is the leading cause of death globally among women, and certain pregnancy complications can be the earliest indicators of increased CVD risk. Nonetheless, there is no recommendation for follow-up of cardiovascular risk factors identified through postpartum screening programs. This study describes current referral practices and clinical course from the Maternal Health Clinic in Kingston, Ontario, for women deemed at high cardiovascular risk postpartum.

Methods: We investigated the cohort of women referred from the postpartum Maternal Health Clinic to cardiology for further assessment and management, specifically examining timing and recommended interventions to reduce CVD risk.

Results: Women referred to cardiology differed significantly from those not referred in history of hypertensive disorders of pregnancy (P < 0.05) and demonstrated a significantly worse CVD risk profile at 6 months postpartum (P < 0.0001). Life expectancy by the cardiometabolic model for women referred was 5 years shorter (P < 0.0001). Only half of the women referred to cardiology scheduled a visit; the median time to the scheduled appointment was 12 months. Of women seen by cardiology, 60% were deemed eligible for cardiac rehabilitation.

Conclusions: Although women at highest risk for CVD are being identified and referred to cardiology, the existing system is not designed for this demographic. Too many women are missing their appointments or being seen beyond 1 year postpartum. To initiate lifestyle changes and/or therapeutic interventions, we suggest that CVD prevention programming begins within 1 year of delivery. Future studies should investigate the viability of traditional cardiac rehabilitation programs among this unique population.

Citing Articles

Developing a question prompt tool to prevent and manage early cardiovascular disease after hypertensive pregnancy: qualitative interviews with women and clinicians.

Theodorlis M, Edmonds J, Sino S, Lyons M, Ramlakhan J, Nerenberg K BMC Womens Health. 2024; 24(1):597.

PMID: 39511595 PMC: 11546220. DOI: 10.1186/s12905-024-03436-x.


Universal Cardiovascular Disease Risk Assessment in Pregnancy: Call to Action Expert Panel.

Hameed A, Tarsa M, Graves C, Grodzinsky A, Thiel de Bocanegra H, Wolfe D JACC Adv. 2024; 3(8):101055.

PMID: 39372368 PMC: 11450966. DOI: 10.1016/j.jacadv.2024.101055.


Adverse Pregnancy Outcomes and Premature Myocardial Infarction: The Clock Is Ticking.

Sarma A, Scott N JACC Adv. 2024; 2(5):100433.

PMID: 38938999 PMC: 11198337. DOI: 10.1016/j.jacadv.2023.100433.


Prevalence of Sex-Specific Cardiovascular Disease Risk Factors, Medical Risk, and Engagement in Health-Promoting Behaviours in Premenopausal Females.

Szakun N, Liva S, Bodner M, Wolff A, Kim M, Cote A CJC Open. 2024; 6(2Part B):301-313.

PMID: 38487073 PMC: 10935687. DOI: 10.1016/j.cjco.2023.11.003.


The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations.

Mulvagh S, Colella T, Gulati M, Crosier R, Allana S, Randhawa V CJC Open. 2024; 6(2Part B):258-278.

PMID: 38487064 PMC: 10935707. DOI: 10.1016/j.cjco.2023.12.001.